reference/8172057

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/8172057

Outgoing Links

Predicate	Object
contentType	Journal Article\|Observational Study\|Research Support, N.I.H., Extramural
endingPage	227
issn	1526-8209
issueIdentifier	3
pageRange	220-227
publicationName	Clinical Breast Cancer
startingPage	220
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_aa048e23fd0358a0129a26ab8c57f3bb http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_e22c906b5d7bce6b1dedece1484fb41e http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_4aa5882c4b10cc954e7ec0c045c1b2c2 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_c13246485dd2e924ba26cd6f8579e248 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_ac2188c8ce8bf49f11f2d85d81d2fe15
bibliographicCitation	Tkaczuk KHR, Hawkins D, Yue B, Hicks D, Tait N, Serrero G. Association of Serum Progranulin Levels With Disease Progression, Therapy Response and Survival in Patients With Metastatic Breast Cancer. Clinical Breast Cancer. 2020 Jun;20(3):220–7. doi: 10.1016/j.clbc.2019.11.010.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_71f3214ddd41bb54edfc0c87134f1cc5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_78c2b1351de2ac3b33393b07ba2abd7a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_34c27cb2a80a85e4a987d7766de180dd http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_005871315395a6b5ce5fcd4e761830cd http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ccfa4000f03a8c81aa002879d6ecbba7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-3607-0273
date	202006
identifier	https://pubmed.ncbi.nlm.nih.gov/PMC8284563 https://doi.org/10.1016/j.clbc.2019.11.010 https://pubmed.ncbi.nlm.nih.gov/31928925
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/27001 https://portal.issn.org/resource/ISSN/1526-8209
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Association of Serum Progranulin Levels With Disease Progression, Therapy Response and Survival in Patients With Metastatic Breast Cancer
discusses	http://id.nlm.nih.gov/mesh/M0167322 http://id.nlm.nih.gov/mesh/M0468341 http://id.nlm.nih.gov/mesh/M000639461 http://id.nlm.nih.gov/mesh/M0027622 http://id.nlm.nih.gov/mesh/M0022149
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D009364Q000453 http://id.nlm.nih.gov/mesh/D014408Q000097 http://id.nlm.nih.gov/mesh/D000077153Q000097 http://id.nlm.nih.gov/mesh/D001943Q000097
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D001943Q000628 http://id.nlm.nih.gov/mesh/D011446 http://id.nlm.nih.gov/mesh/D009364Q000517 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D053208 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D011237 http://id.nlm.nih.gov/mesh/D018714 http://id.nlm.nih.gov/mesh/D018396Q000097 http://id.nlm.nih.gov/mesh/D008408 http://id.nlm.nih.gov/mesh/D000369 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D018450 http://id.nlm.nih.gov/mesh/D066066 http://id.nlm.nih.gov/mesh/D001943Q000175 http://id.nlm.nih.gov/mesh/D001943Q000401
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_9d7fe60f25abdf582afc7cdca238bde8 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7102 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_ac01483d7b4234aab3aa9d50fde3982a http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_7ed75134b36b0e173fb44798462e4e66 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11431

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2896

Total number of triples: 65.